Home › Funds › Soleus Capital Management, L.P. › NPCE
Soleus Capital Management, L.P. position in NPCE
NEUROPACE INC COM · Health Care
Soleus Capital Management, L.P. reported holding 2,911,122 shares of NPCE (NEUROPACE INC COM) in its Q2 2026 13F filing — a position valued at US$46.3M, representing 1.59% of its reported portfolio and ranking #16 among its reported holdings. Soleus Capital Management, L.P. has disclosed NPCE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s NPCE position evolved
Soleus Capital Management, L.P. first disclosed a stake in NPCE in Q3 2023 at 2,466,205 shares (US$24.0M). The position peaked in Q2 2026 at 2,911,122 shares, worth US$46.3M. Across 12 filings, Soleus Capital Management, L.P. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,911,122 shares valued at US$46.3M — a reduction of -21,085 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2025 (shares rose 50% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.47M | $24.00M | New |
| Q4 2023 | 2.43M | $25.09M | Reduce |
| Q1 2024 | 2.43M | $32.12M | Hold |
| Q2 2024 | 2.43M | $18.39M | Hold |
| Q3 2024 | 2.43M | $16.96M | Hold |
| Q4 2024 | 2.43M | $27.23M | Hold |
| Q1 2025 | 2.61M | $32.05M | Add |
| Q2 2025 | 2.31M | $25.77M | Reduce |
| Q3 2025 | 2.96M | $30.50M | Add |
| Q4 2025 | 2.70M | $41.74M | Reduce |
| Q1 2026 | 2.93M | $38.56M | Add |
| Q2 2026 | 2.91M | $46.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NPCE and 13F data
NPCE (NEUROPACE INC COM) is a Health Care company. 47 other funds we track also report a position in NPCE — the largest reported positions include First Light Asset Management, LLC (US$45.5M), Palumbo Wealth Management LLC (US$3.3M), HighMark Wealth Management LLC (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NPCE
- First Light Asset Management, LLC 2.86M sh · $45.46M · Q2 2026
- Palumbo Wealth Management LLC 209.20K sh · $3.32M · Q2 2026
- HighMark Wealth Management LLC 163.00K sh · $2.59M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held NPCE?
Soleus Capital Management, L.P. has disclosed NPCE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in NPCE?
As of Q2 2026, Soleus Capital Management, L.P. holds 2.91M shares of NPCE (NEUROPACE INC COM), valued at $46.26M, representing 1.59% of its reported portfolio and ranking #16.
Has Soleus Capital Management, L.P. been buying or selling NPCE?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in NPCE. The position peaked in Q2 2026 at 2.91M shares.
Which other funds hold NPCE?
Other major institutional holders of NPCE include First Light Asset Management, LLC, Palumbo Wealth Management LLC, HighMark Wealth Management LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.